Praxbind

Praxbind Side Effects

idarucizumab

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH

Marketer:

Boehringer Ingelheim
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Side Effects
In a phase III trial the safety of PRAXBIND has been evaluated in 503 patients, who had uncontrolled bleeding or required emergency surgery or procedures and were under treatment with PRADAXA, as well as in 224 volunteers in phase I trials.
No adverse reactions have been identified.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in